A citizen petition names names

FDA Radar reads four sources every day, and none of them is a docket. That isn’t an oversight — a citizen petition isn’t addressed to a device, a product code, or a company’s registration number the way a warning letter or a 510(k) record is. It is addressed to FDA itself, asking the agency to do something, and it can ask about almost anything FDA has the power to do.

What a citizen petition can actually ask for

Under 21 CFR 10.30, any person — a competitor, a law firm, a patient advocacy group, an individual — can petition FDA’s Commissioner to issue, amend, or revoke a regulation or order, or to take or refrain from taking any other form of administrative action. That second clause is the whole of the mechanism’s reach. A reclassification petition under 21 CFR 860.123 can only ask FDA to move a device type to a different class. A citizen petition has no such ceiling: it can name a single competitor’s single product and ask FDA to suspend a clearance, tighten a special-controls guidance against it, or open an enforcement inquiry. The petition has to earn that ask, too — 10.30(b) requires a full statement of the petitioner’s grounds, and a signed certification that the filing includes any information the petitioner knows of that is unfavorable to its own request, not just the material that supports it.

A public docket, on a clock FDA can’t skip silently

A citizen petition is filed as a docket on regulations.gov or by mail to FDA’s Division of Dockets Management, and it becomes a public record the moment it is filed — open for anyone to read and comment on, the same day. Section 10.30(e)(2) then puts FDA on a clock: a response within 180 days of receipt, with narrow statutory exceptions that don’t apply to device petitions. FDA doesn’t have to grant or deny inside that window, though. The rule lets it file a tentative response instead — a letter explaining why the agency hasn’t reached a decision, which satisfies the 180 days without resolving anything. A petition can sit open, tentatively answered, for years.

The docket doesn’t go quiet when the 180 days pass. It goes tentative — and can stay that way for exactly as long as FDA wants it to.

Why the four sources never reach it

Federal Register notices, warning letters, device recalls, and 510(k) clearances — the sources FDA Radar reads, and says so — are all records of an FDA decision already made public through the agency’s own device-specific channels. A citizen petition lives upstream of that, inside a comment-and-response docket system built for the whole agency, not devices specifically, and indexed by docket number rather than K-number or product code. The two systems touch at one point only: if a petition’s grant eventually produces a new rule or classification change, that shows up in the Federal Register under its own notice, with nothing in it pointing back to the petition that started it. Everything before that — the filing, the public comments, any tentative response — sits in a system no device-portfolio monitoring tool, including this one, reaches into today.

The practice

A competitor’s citizen petition naming your device, or your own petition against a competitor’s, will not appear as an item in any device-monitoring feed. Reading one means searching regulations.gov directly — by company name, device type, or product code — on your own schedule, not waiting for it to surface elsewhere. Whether a specific petition is worth responding to, and what a competitor’s filing means for your own submission strategy, is a determination for a regulatory professional working the docket directly. This is regulatory intelligence about where the mechanism lives, never regulatory advice about any specific petition.